Metabolomics,Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Identification of a Novel Angiogenesis and Tumor Suppressor Gene Rab25 in Esophageal Squamous Cell Carcinoma


ABSTRACT: Twelve clinical samples from human esophageal squamous cell carcinoma (ESCC) (seven tumors and five non-tumors) were sequenced using Illumina high-throughput sequencing and the RNA-Seq profiling was investigated with 1730 genes significantly differentially expressed. The gene Rab25 was found to be down-regulated in tumors (p-value < 1E-20) and identified as a novel candidate tumor suppressor gene. The down-regulation of Rab25 was examined in a large cohort of ESCC and non-tumor cases by qPCR and immunohistochemistry analyses. Aberrant methylation in the promoter region of Rab25 was studied by demethylation treatment with 5-aza-dC and bisulfite genomic sequencing (BGS). In order to assess the effect of Rab25 on tumor growth and angiogenesis, in vitro and in vivo functional studies in ESCC cell lines using lentiviral-based overexpression or knockdown models were also performed. 7 tumor and 5 normal samples

ORGANISM(S): Homo sapiens

SUBMITTER: Jessie Yun-juan Bao 

PROVIDER: E-GEOD-32424 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

altmetric image

Publications

Rab25 is a tumor suppressor gene with antiangiogenic and anti-invasive activities in esophageal squamous cell carcinoma.

Tong Man M   Chan Kwok Wah KW   Bao Jessie Y J JY   Wong Kai Yau KY   Chen Jin-Na JN   Kwan Pak Shing PS   Tang Kwan Ho KH   Fu Li L   Qin Yan-Ru YR   Lok Si S   Guan Xin-Yuan XY   Guan Xin-Yuan XY   Ma Stephanie S  

Cancer research 20120918 22


Esophageal squamous cell carcinoma (ESCC), the major histologic subtype of esophageal cancer, is a devastating disease characterized by distinctly high incidences and mortality rates. However, there remains limited understanding of molecular events leading to development and progression of the disease, which are of paramount importance to defining biomarkers for diagnosis, prognosis, and personalized treatment. By high-throughout transcriptome sequence profiling of nontumor and ESCC clinical sam  ...[more]

Similar Datasets

2012-06-01 | E-GEOD-29968 | biostudies-arrayexpress
2012-12-05 | GSE32424 | GEO
2011-05-31 | E-GEOD-23036 | biostudies-arrayexpress
2016-03-03 | E-GEOD-78813 | biostudies-arrayexpress
2016-06-30 | E-GEOD-55856 | biostudies-arrayexpress
2012-12-31 | E-GEOD-39957 | biostudies-arrayexpress
2011-12-01 | E-GEOD-31430 | biostudies-arrayexpress
2013-04-02 | E-GEOD-33294 | biostudies-arrayexpress
2013-03-21 | E-GEOD-45350 | biostudies-arrayexpress
2014-04-08 | E-GEOD-46046 | biostudies-arrayexpress